The public's help is being enlisted in the Microbiome Immunity Project, what's thought to be the biggest study to date of the human microbiome — the communities of bacteria and other microbes that live in and on the human body, where they influence our health.
Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.
The University of California San Diego has been ranked the 15th best university in the world by the 2017 Academic Ranking of World Universities (ARWU). UC San Diego was also named the world’s third best public college. The campus was named the world’s fourth best public college and nationally, UC San Diego was recognized as the country’s 13th best university.
The study -- led by QI affiliate Cinnamon Bloss -- was published in today's edition of the Journal of the American Medical Association and suggests a strong resistance to the use of genetically engineered mosquitoes for controlling disease.
Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.
QI Innovation Space member CARI Therapeutics has received a grant from the National Institutes of Health to collaboratively develop a biosensor that will detect the presence of opioids in patients in recovery.
The San Diego Union-Tribune, April 25
La Jolla Light, April 23
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
